P61 Health State Utility Values and Quality of Life in Patients Receiving Ripretinib in the Phase 3 Invictus Trial and a Real-World Evidence Study in China

Autor:	RL Jones, JY Blay, P Chi, S Bauer, H Gelderblom, L Shen, YL He, MC Heinrich, P Schöffski, JR Zalcberg, B Harrow, ML Sherman, R Ruiz-Soto, C Becker, M von Mehren
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S14-S15
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::48c38894ba35327fec72c47c58810961 https://doi.org/10.1016/j.jval.2022.09.073 Zobrazit plný text záznamu Full Text from ScienceDirect